Gentamicin ointment is a topical antibiotic used to treat bacterial skin infections caused by susceptible gram-negative and some gram-positive bacteria. It is applied directly to the skin to prevent or stop localized infection in wounds, cuts, burns, or abrasions.
The active ingredient, gentamicin sulfate, is an aminoglycoside antibiotic that inhibits bacterial protein synthesis. It binds to the 30S ribosomal subunit, causing misreading of mRNA and halting protein production. This mechanism disrupts essential cellular functions in bacteria, leading to cell death.
Topical gentamicin ointment is not effective against viral or fungal infections. It is specifically designed for superficial bacterial contamination. The ointment is available over the counter in the U.S. under brand names such as Garamycin and in generic forms. It is not intended for internal use or systemic absorption.
Gentamicin ointment works by targeting bacterial ribosomes. Once applied to the skin, the drug diffuses into the infected tissue and enters bacterial cells through passive diffusion and active transport mechanisms. Inside the cell, it binds irreversibly to the 30S ribosomal subunit, disrupting the initiation complex during translation.
This binding causes misreading of the genetic code, resulting in faulty proteins. These defective proteins accumulate and compromise membrane integrity, leading to cell lysis. The effect is bactericidal, meaning it kills bacteria rather than just stopping their growth.
Because gentamicin is poorly absorbed through intact skin, systemic side effects are rare with topical use. However, prolonged application or use on broken skin increases the risk of absorption, especially in children or individuals with compromised renal function.
Gentamicin ointment is prescribed or recommended for minor skin infections such as impetigo, folliculitis, and infected insect bites. It is also used prophylactically in minor surgical wounds or post-procedure care to reduce infection risk.
A clinical study published in the Journal of Clinical and Experimental Dermatology found that 87% of patients with mild to moderate impetigo showed resolution within five days of twice-daily application of gentamicin ointment. The study included 120 participants aged 6 to 65, with no significant adverse events reported.
It is often used in combination with other treatments. For example, in cases of infected eczema, gentamicin ointment may be applied after a corticosteroid cream to manage both inflammation and infection. However, this dual therapy should be limited to short durations due to the risk of skin thinning and secondary resistance.
Gentamicin ointment comes in several formulations, primarily differing in base and concentration:
| Formulation | Concentration | Base Type | Use Case |
|---|---|---|---|
| Standard ointment | 0.1% | Petrolatum-based | General wound care, minor infections |
| Preservative-free | 0.1% | Water-soluble | Sensitive skin, mucosal areas (e.g., around eyes) |
| Combination ointment | 0.1% gentamicin + 1% hydrocortisone | Petrolatum | Inflamed, infected skin (short-term use only) |
Preservative-free versions are recommended for infants and those with known sensitivities. The water-soluble base allows easier cleaning and reduces occlusion, which may lower the risk of folliculitis.
One non-obvious fact: gentamicin ointment is ineffective against methicillin-resistant Staphylococcus aureus (MRSA). A 2021 review in the American Journal of Clinical Dermatology confirmed that MRSA strains are inherently resistant to gentamicin due to enzymatic modification of the drug.
Gentamicin ointment is widely used in outpatient settings, including primary care clinics, urgent care centers, and home first aid kits. Its low cost and broad availability make it a common choice for treating uncomplicated skin infections.
It is particularly useful in resource-limited environments. According to the World Health Organization (WHO), gentamicin is listed in the Model List of Essential Medicines for topical use in treating skin infections in low-income countries.
Despite its widespread use, it is not recommended for deep or puncture wounds. A 2019 study in the Journal of Wound Care found that topical gentamicin failed to penetrate beyond 1 mm of tissue depth, making it ineffective for deeper infections requiring systemic antibiotics.
Many users apply gentamicin ointment to conditions it cannot treat. It is frequently misused for cold sores, acne, or fungal rashes. Cold sores are caused by herpes simplex virus, and gentamicin has no antiviral activity. Acne involves Propionibacterium acnes, which is generally resistant to gentamicin.
Another mistake is using it for healing without infection. Applying antibiotic ointment to clean, unbroken skin offers no benefit and increases the risk of developing resistant bacteria. The CDC warns that unnecessary use of topical antibiotics contributes to antimicrobial resistance.
I once observed a patient applying gentamicin ointment daily to a healed scar from a burn. After six weeks, the area developed a persistent red rash and crusting. A dermatologist diagnosed contact dermatitis likely triggered by prolonged exposure to the ointment base and preservatives.
Do not use gentamicin ointment on open wounds with heavy exudate, deep abscesses, or signs of systemic infection such as fever or lymphangitis. These require medical evaluation and possibly oral or intravenous antibiotics.
It should not be applied near the eyes or mucous membranes unless specifically directed by a healthcare provider. The ointment can cause corneal irritation or damage if it enters the eye. If accidental contact occurs, rinse thoroughly with saline or water.
Patients with known hypersensitivity to aminoglycosides should avoid it. Cross-reactivity with other aminoglycosides like amikacin or tobramycin is possible. Signs of allergic reaction include itching, swelling, or blistering at the application site.
Gentamicin ointment differs from other common topical antibiotics in spectrum and stability:
| Antibiotic | Target Bacteria | Stability | Resistance Risk |
|---|---|---|---|
| Gentamicin | Gram-negative (E. coli, Pseudomonas), some gram-positive | High (stable at room temp) | Low to moderate (resistance via modifying enzymes) |
| Neomycin | Gram-negative and positive, but less effective against Pseudomonas | Moderate (degrades in light) | High (common allergy and resistance) |
| Mupirocin | Primarily staphylococci and streptococci | Low (requires refrigeration) | Emerging (resistance in MRSA) |
Neomycin is more allergenic than gentamicin. Mupirocin is preferred for nasal decolonization of MRSA but is less effective against Pseudomonas species.